Showing results (321-330 of 3,013) with videos related to
Sort By:
Pageof 302
Cardiovascular Drugs and Therapy|August 30, 2012
Prasugrel versus high dose clopidogrel to overcome early high on clopidogrel platelet reactivity in patients with ST elevation myocardial infarctionD Alexopoulos, K C Theodoropoulos, E F Stavrou, et al.Cardiovascular Drugs and Therapy|April 30, 2004
The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)Willem J Remme, Guenter Riegger, Per Hildebrandt, et al.Cardiovascular Drugs and Therapy|April 27, 2004
Cardiovascular drugs and serum uric acidAriel J ReyesCardiovascular Drugs and Therapy|April 27, 2004
A comprehensive description of muscle symptoms associated with lipid-lowering drugsSylvia Franc, Sylvie Dejager, Eric Bruckert, et al.Cardiovascular Drugs and Therapy|April 27, 2004
The role of clopidogrel in the management of patients with ischemic heart diseaseV Chopra, J D Marmur, E CavusogluCardiovascular Drugs and Therapy|September 29, 2005
Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literatureJens Rosenberg, Finn Gustafsson, Søren Galatius, et al.Cardiovascular Drugs and Therapy|September 28, 2005
Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failureIain M MacIntrye, Pardeep S Jhund, John J V McMurrayCardiovascular Drugs and Therapy|September 28, 2005
Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery diseaseJohn P Lekakis, Athanassios Protogerou, Christos Papamichael, et al.Cardiovascular Drugs and Therapy|February 18, 2005
Cardioprotective action of perindopril versus candesartan in renovascular hypertensive ratsMakoto Nagai, Kazuaki Horikoshi, Takehiko Izumi, et al.Cardiovascular Drugs and Therapy|February 18, 2005
Cost-effectiveness of losartan versus atenolol in treating hypertension--an analysis of the LIFE study from a Swiss perspectiveThomas D Szucs, Michel Burnier, Paul ErnePageof 302